ABOUT B0KEP 2025

The FDA didn’t outright reject the applying, but questioned for another Section 3 clinical demo, which can likely take a couple of several years to finish and resubmit towards the FDA. With Lykos going back for the drawing board, who’s going to get the subsequent swing at FDA acceptance?One exception to my coverage of counting on Bloomberg in t